Duloxetine Contributing to a Successful Multimodal Treatment Program for Peripheral Femoral Neuropathy and Comorbid ‘Reactive Depression’ in an Adolescent
In the United States, duloxetine has been approved for the treatment of major depressive disorder, diabetic peripheral neuropathic pain and fibromyalgia in the adult population. Data regarding the use of duloxetine in the pediatric population, however, are very limited. Femoral nerve injury is a rar...
Saved in:
Main Authors: | Ludmyla Kachko, Shiri Ben Ami, Alon Liberman, Einat Birk, Sefi Kronenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Pain Research and Management |
Online Access: | http://dx.doi.org/10.1155/2011/164984 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Coasting related to taxane-induced peripheral neuropathy in patients with breast cancer: a systematic review
by: Freja L. Kruse, et al.
Published: (2025-01-01) -
Comparison of Efficacy of Duloxetine Versus Amitriptyline in Fibromyalgia Patients
by: Saira Tahir, et al.
Published: (2024-12-01) -
Duloxetine for Postoperative Pain in Orthopedic Surgeries: A Review Article
by: Alireza Nankali, et al.
Published: (2024-12-01) -
Progress on spinal cord stimulation in treatment of peripheral neuropathy
by: ZONG Yun⁃fei, et al.
Published: (2025-01-01) -
Peripheral neuropathy as initial manifestation of Churg-Strauss Syndrome
by: Antonio Villa, et al.
Published: (2020-03-01)